Category: Covid-19 Vaccine

Page 446«..1020..445446447448..460470..»

Nearly 13% of Nevadans have missed their second COVID-19 vaccine dose – FOX5 Las Vegas

April 28, 2021

'); $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).append(""+val.title+""); if (val.poly != "" && val.polyimg != "") { $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).append('"+val.ihtml+""); $("#expandable-weather-block .weather-index-alerts").show(); $("#expandable-weather-block .modal-body h2").css({"font-family":"'Fira Sans', sans-serif", "font-weight":"500", "padding-bottom":"10px"}); $("#expandable-weather-block .modal-body p").css({"font-size":"14px", "line-height":"24px"}); $("#expandable-weather-block .modal-body span.wxalertnum").css({"float":"left", "width":"40px", "height":"40px", "color":"#ffffff", "line-height":"40px", "background-color":"#888888", "border-radius":"40px", "text-align":"center", "margin-right":"12px"}); $("#expandable-weather-block .modal-body b").css("font-size", "18px"); $("#expandable-weather-block .modal-body li").css({"font-size":"14px", "line-height":"18px", "margin-bottom":"10px"}); $("#expandable-weather-block .modal-body ul").css({"margin-bottom":"24px"}); $("#expandable-weather-block .modal-body pre").css({"margin-bottom":"24px"}); $("#expandable-weather-block .modal-body img").css({"width":"100%", "margin-bottom":"20px", "borderWidth":"1px", "border-style":"solid", "border-color":"#aaaaaa"}); $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).css({"borderWidth":"0", "border-bottom-width":"1px", "border-style":"dashed", "border-color":"#aaaaaa", "padding-bottom":"10px", "margin-bottom":"40px"}); }); } function parseAlertJSON(json) { console.log(json); alertCount = 0; if (Object.keys(json.alerts).length > 0) { $("#mrd-wx-alerts .modal-body ").empty(); } $.each(json.alerts, function(key, val) { alertCount++; $("#mrd-wx-alerts .alert_count").text(alertCount); $("#mrd-wx-alerts .modal-body ").append(''); $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(""+val.title+""); if (val.poly != "" && val.polyimg != "") { $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(''); } else if (val.fips != "" && val.fipsimg != "") { // $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(''); } $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(val.dhtml+"

Instruction

Go here to see the original:

Nearly 13% of Nevadans have missed their second COVID-19 vaccine dose - FOX5 Las Vegas

Austin podcaster Joe Rogan advised healthy young adults against COVID-19 vaccines. Here’s what the doctors say – KVUE.com

April 28, 2021

While young adults may have a lower risk of developing serious complications, they do tend to have a higher chance of spreading the virus.

AUSTIN, Texas Popular podcaster and Central Texas resident Joe Rogan is sparking controversy online for what he said about recommending COVID-19 vaccines to certain people.

On his podcast, "The Joe Rogan Experience," he advocated against healthy young adults receiving a COVID-19 vaccine.

"And people say, 'Do you think it's safe to get vaccinated?' I've said, 'Yeah, I think for the most part it's safe to get vaccinated, I do, I do,'" he said. "But if you're like 21 years old, you say to me, 'Should I get vaccinated?' I go, 'No.' Are you healthy? Are you a healthy person? Don't do anything stupid but you should take care of yourself."

Rogan's no doctor, but his audience is large. His podcast was reportedly the most popular one on Spotify last year.

Doctors and government leaders from both sides of the aisle have encouraged young people to get vaccinated because while they may not get the most severe symptoms from COVID-19, they may be more likely to gather in social settings where the virus can spread.

In fact, a CDC report from June to August 2020 found that COVID-19 incidence was the highest in people ages 20 to 29, who accounted for more than 20% of all confirmed cases.

"Strict adherence to community mitigation strategies and personal preventive behaviors by younger adults is needed to help reduce infection and subsequent transmission to persons at higher risk for severe illness," the report said.

Other health experts including Dr. Mark Escott, Austin Public Health's Interim Health Authority have said that while the likelihood of dying from COVID-19 is lower for young adults, it is possible.

"Younger people are less likely to have severe disease. They're a lot less likely to die. But those chances are larger than zero," Dr. Escott said during an Austin City Council joint meeting with the Travis County Commissioners Court on April 13.

In Travis County, as of April 24, six people 20 to 29 years old have died from COVID-19.

As of April 23, the latest data on theTexas Department of State Health Services COVID-19 dashboard shows 48,897 people have died in Texas because of COVID-19. People 20 to 29 years old accounted for 238 of the reported deaths.

During a CDC Partner Call in October, Dr. Greta Massetti said it is important for young adults to try to stop the spread of COVID-19.

"Although young adults are reported to experience lower risks for severe disease and death from infection with SARS-CoV-2, they can experience severe disease themselves and can transmit an infection to others at higher risk for severe illness," Dr. Massetti said. "There is an urgent need to reduce the spread of COVID-19 among young adults."

According to the CDC, COVID-19 vaccinations are key to not just preventing illness in individuals, but stopping the pandemic overall.

Currently in Texas, anyone over the age of 16 is eligible for the Pfizer vaccine, while those 18 years or older are permitted to receive the Moderna or Johnson & Johnson. The CDC recommendspeople get vaccinated "as soon as you are eligible."

See more here:

Austin podcaster Joe Rogan advised healthy young adults against COVID-19 vaccines. Here's what the doctors say - KVUE.com

Will I have worse COVID-19 vaccine symptoms if Ive already had the virus? – WAVY.com

April 28, 2021

by: Kaylee DeWitt, Nexstar Media Wire

THORNTON, CO MARCH 06: Prepared doses of the Johnson & Johnson COVID-19 vaccine, the newest vaccine approved by the U.S. FDA for emergency use, sit in a box at an event put on by the Thornton Fire Department on March 6, 2021 in Thornton, Colorado. Colorado entered COVID-19 vaccination Phase 1B.3 on Friday, allowing essential grocery and agriculture workers, people over the age of 60 and people with two or more high-risk conditions to receive a vaccine. (Photo by Michael Ciaglo/Getty Images)

(KTVX) You may have heard that those who have already been sick with COVID-19 experience worse symptoms after receiving the vaccine. But is this accepted by the medical community, or is it just a myth?

According to Dr. Eddie Stenehjem, an infectious diseases physician at Intermountain Healthcare in Utah, there is some observational data that those whove had COVID-19 get pretty symptomatic after their first dose of the COVID-19 shot.

On the other hand, most people that havent had COVID-19, take the first shot, no problem, he said. Dont react, maybe have a sore arm. And then their second shot, they can be symptomatic with fevers, chills, kind of feeling rundown.

He said this happens because, for those who have had COVID-19, that first shot is really their booster shot, so thats the shot that they tend to become symptomatic from. And thats completely normal, Stenehjem said.

There is some data and a lot of people talking about this if youve had COVID-19 that you may only need one shot of Pfizer and Moderna because thats truly your booster shot. We dont have any good clinical data on that. Thats work thats in progress, but that is something that may come to fruition that people whove had COVID only necessary only need one shot that acts as your booster, he explained.

Dr. Emily Spivak, from the Division of Infectious Diseases at University of Utah Health, said much the same.

She said published data shows that people who have had COVID-19 prior to receiving the vaccine experience an increased rate of local or systemic side effects such as fevers, chill, muscle aches, fatigue, and headaches after the first vaccine dose versus those who havent.

Its not 100%, but the overall rate is higher, Spivak explained.

And, she said, this makes sense because what is happening since that first dose is recalling the immune system and reminding the bodys immune system that it has seen COVID-19 before, and part of that immune response is, again, these side effects. Its kind of like having a flu-like illness.

If the vaccine is acting as a booster for the previously infected, is there a chance that these people will only need one shot of Pfizer or Moderna?

Thats one thing that has been proposed, Spivak said. Those who have had COVID-19 often have a high antibody response after just the first dose, she explained.

There was some suggestion that maybe one dose was enough and that could be a way to stretch the vaccine supply. That practice was never implemented in the U.S., she said. But it is unknown for how long that antibody response would last compared to a two-dose series.

I suspect a fair number of them would be protected with just one dose, Spivak said.

Though it is still unknown whether or not one dose could be enough for those who have had COVID-19, Spivak said that having two doses of the vaccine is not dangerous by any means.

For more information on this topic, see information from the New England Journal of Medicine included below.

Excerpt from:

Will I have worse COVID-19 vaccine symptoms if Ive already had the virus? - WAVY.com

NY expanding walk-in appointments at mass Covid-19 vaccination sites – syracuse.com

April 28, 2021

Johnson City, N.Y. Anyone in New York age 16 and up can get a Covid-19 vaccine without an appointment starting Thursday, Gov. Andrew Cuomo said today.

All mass vaccination sites run by the state will take walk-ins for Covid shots starting that day. The state opened walk-in vaccines to those age 60 and up last week.

The state is trying to remove as many obstacles to getting a shot as possible, Cuomo said during a press conference in Johnson City. He acknowledged today that demand for vaccines has eased after arguing last week that supply was still the problem.

Mass vaccination sites around the state have thousands of appointments available, including same-day time slots.

You dont have to call. You dont have to make an appointment, Cuomo said. All the obstacles are removed. All the barriers are removed. Just show up and roll up your sleeve.

Local governments that run their own vaccine clinics will also have the option to accept walk-ins starting Thursday, Cuomo said.

This is our way of saying, if you were intimidated by the process of trying to make an appointment, thats gone, he said. Come in and get a vaccine.

MORE ON CORONAVIRUS

Coronavirus in NY: Cases, maps, charts and resources

Cuomo says NYS Fair will happen in 2021: The Fair must go on

2021 NY State Fair: All tickets $3 and Midway returns. But will masks be required?

NY raising capacity limits for gyms, stadiums, casinos, offices

Complete coronavirus coverage on syracuse.com

Contact Kevin Tampone anytime: Email | Twitter | Facebook | 315-282-8598

Read the rest here:

NY expanding walk-in appointments at mass Covid-19 vaccination sites - syracuse.com

Are COVID-19 vaccine symptoms worse for people whove already had the virus? – KXAN.com

April 28, 2021

`;// articleContent = document.querySelector(".article-content");// articleContent.innerHTML = articleContent.innerHTML + formbox;let firstParagraph = document.querySelector("div.article-content > p:nth-child(1)");if (firstParagraph !== null) {firstParagraph.insertAdjacentHTML("afterend", formbox);}function waitForElement(id, callback){var goStahp = setInterval(function(){if(document.getElementById(id)){clearInterval(goStahp);callback();}}, 100);}waitForElement("JotFormIFrame-202185815209151", function(){const expandButton = document.querySelector('h3.expand_box_click_to_open_covid_form');expandButton.addEventListener('click', function() {let box = document.querySelector('.corona_form_expand_box_covid_form');let first = 'opening';let second = 'open';let buttonAction = 'Hide story tip submission form';let deviceAction = "Tap";if (window.innerWidth > 666) {deviceAction = "Click";}// console.log(window.innerWidth);if(box.classList.contains(first)) {[first, second] = [second, first];buttonAction = `${deviceAction} to submit a coronavirus story tip`;}expandButton.innerHTML = buttonAction;box.classList.toggle(first);setTimeout(() => {box.classList.toggle(second);}, 0);});var ifr = document.getElementById("JotFormIFrame-202185815209151");if(window.location.href && window.location.href.indexOf("?") > -1) {var get = window.location.href.substr(window.location.href.indexOf("?") + 1);if(ifr && get.length > 0) {var src = ifr.src;src = src.indexOf("?") > -1 ? src + "&" + get : src + "?" + get;ifr.src = src;}}window.handleIFrameMessage = function(e) {if (typeof e.data === 'object') { return; }var args = e.data.split(":");if (args.length > 2) { iframe = document.getElementById("JotFormIFrame-" + args[(args.length - 1)]); } else { iframe = document.getElementById("JotFormIFrame"); }if (!iframe) { return; }switch (args[0]) {case "scrollIntoView":iframe.scrollIntoView();break;case "setHeight":console.log(`case: setHeight`);iframe.style.height = parseInt(args[1]) + 15 + "px";break;case "collapseErrorPage":console.log(`case: collapseErrorPage`);if (iframe.clientHeight > window.innerHeight) {iframe.style.height = window.innerHeight + "px";}break;case "reloadPage":window.location.reload();break;case "loadScript":var src = args[1];if (args.length > 3) {src = args[1] + ':' + args[2];}var script = document.createElement('script');script.src = src;script.type = 'text/javascript';document.body.appendChild(script);break;case "exitFullscreen":if (window.document.exitFullscreen) window.document.exitFullscreen();else if (window.document.mozCancelFullScreen) window.document.mozCancelFullScreen();else if (window.document.mozCancelFullscreen) window.document.mozCancelFullScreen();else if (window.document.webkitExitFullscreen) window.document.webkitExitFullscreen();else if (window.document.msExitFullscreen) window.document.msExitFullscreen();break;}var isJotForm = (e.origin.indexOf("jotform") > -1) ? true : false;if(isJotForm && "contentWindow" in iframe && "postMessage" in iframe.contentWindow) {var urls = {"docurl":encodeURIComponent(document.URL),"referrer":encodeURIComponent(document.referrer)};iframe.contentWindow.postMessage(JSON.stringify({"type":"urls","value":urls}), "*");}};if (window.addEventListener) {window.addEventListener("message", handleIFrameMessage, false);} else if (window.attachEvent) {window.attachEvent("onmessage", handleIFrameMessage);}});//

Link:

Are COVID-19 vaccine symptoms worse for people whove already had the virus? - KXAN.com

Want That Job Offer? A Covid-19 Vaccine Is Now Required. – The Wall Street Journal

April 26, 2021

At the New York restaurant Eleven Madison Park, a recent job posting for a sommelier lists a string of necessary skills, including exceptional wine knowledge and an ability to lift 50 pounds. The last requirement on the list: a Covid-19 vaccination.

As the U.S. job market heats up, positions operating machines in Louisville, Ky., working in offices in Houston and waiting on diners in Manhattan now require that candidates be vaccinatedor be willing to get their Covid-19 shot within 30 days of hire.

These mandates are in their early stages, making it tough to determine how many U.S. employers now require vaccines. Companies largely have been reluctant to require shots, at first because vaccines were scarce, and more recently because bosses feared blowback from their employees, employment attorneys and human-resources executives say.

The latest federal data show that half of American adults have had at least one shot, and vaccines are now open to all adults in the U.S.Thats made some employers feel more comfortable putting requirements in place. Polling suggests a swath of the population remains wary, hesitant because of the vaccines possible side effects, safety concerns or a mistrust of drugmakers or the government.

The Houston Methodist Hospital network is mandating vaccines for both existing employees and new hires, barring an exemption. Those who fail to comply will at first be suspended without pay, and later terminated, a hospital spokeswoman says. Houston Methodist believes employee vaccinations are essential to keeping patients safe.

Originally posted here:

Want That Job Offer? A Covid-19 Vaccine Is Now Required. - The Wall Street Journal

Covid-19 Vaccine Passports, Passes and Apps Around the Globe – The New York Times

April 26, 2021

Isnt the European Union also developing a system? Yes. On June 21, the E.U. is expected to introduce a certificate called a Digital Green Pass, with the aim of allowing people who have been vaccinated against the coronavirus to travel more freely. Under the proposed rules, each nation within the bloc could decide which travel restrictions, such as obligatory quarantine, to waive for Digital Green holders. But many countries, including Denmark, say they cannot afford to wait for the Digital Green Pass and are developing their own versions.

Name of card: The Green Pass

Could it get you an indoor table? Yes.

How about entry to a concert or sports game? That, too.

Anything else? The pass allows you to enter many businesses, including swimming pools, gyms, theaters and wedding halls, as well as cultural events, such as concerts, sports games and religious gatherings. Having the pass may also mean that you may not have to quarantine for 10 to 14 days after international travel.

How does it work? In late February, Israels ministry of health began offering the Green Pass to fully vaccinated residents and individuals who have recovered from Covid-19. When booking a table at a restaurant, many of the businesses began to ask, Do you have a Green Pass? Israelis can print their certificates containing a QR code, download the code onto their phones or flash the app itself.

Whats with that family? The app and other Green Pass materials feature an animated illustration of a family of three. The man is wearing shorts, a backpack and a camera around his neck, suggesting hes on vacation. His son and wife are wearing masks, but their postures are relaxed as they pull their suitcases.

Aparna Nair, a professor of science history at the University of Oklahoma who maintains a collection of vaccination certificates going back to the 1820s, said that this detail was noteworthy: They are using the design of the vaccine passport to form visual connections with life after the pandemic, essentially, the vaccine as a literal passport to the rest of the world.

See the original post here:

Covid-19 Vaccine Passports, Passes and Apps Around the Globe - The New York Times

There’s Room for More Players in the Covid-19 Vaccine Market, Analyst Says – Barron’s

April 26, 2021

Text size

As expectations grow that messenger RNA-based vaccines such as those developed by Pfizer and Moderna will dominate the Covid-19 vaccine market, analysts say there will be room for smaller players alongside those two firms.

In a note published early Monday, an analyst at Guggenheim Securities initiated coverage of CureVac (ticker: CVAC), which is developing an mRNA-based Covid-19 vaccine now in clinical trials, with a Neutral rating and no target price.

Shares of CureVac, which went public in August, have skyrocketed in recent months. The stock is up 43.5% so far this year and is up another 1.7% to about $118 in trading on Monday.

In less than 12 months from its IPO, we believe CVAC has the potential to evolve from a research driven mRNA company to a fully integrated biopharma vaccine manufacturer and developer, assuming [its Covid-19 vaccine] succeeds in preventing symptomatic COVID-19 disease in its upcoming Phase 2/3 HERALD study, Guggenheim analyst Seamus Fernandez wrote.

Messenger RNA-based vaccines are based on a novel technology that had not been used in an approved or authorized medicine of any kind before the Pfizer vaccine received U.S. Food and Drug Administration authorization late last year. They work differently than the adenoviral vector-based vaccines developed by Johnson & Johnson (JNJ) and AstraZeneca (AZN), which also use a novel approach. Johnson & Johnson and AstraZeneca have both faced manufacturing troubles and safety concerns, though regulators say the benefits of the vaccines continue to outweigh the risks.

In his note, Fernandez wrote that he expects CureVac to claim a modest share of pandemic-era sales of the Covid-19 vaccine in developed world markets.But he said that he thinks the vaccine can capture 20% of global endemic sales by or before 2024.

Newsletter Sign-up

Every weekday evening we highlight the consequential market news of the day and explain what's likely to matter tomorrow.

We think demand for SARS-CoV-2 vaccines is here to stay and mRNA vaccines will dominate the global landscape long-term, he wrote.

Fernandez estimated annual sales of between $3 billion and $3.5 billion of CureVacs Covid-19 vaccine after the pandemic, and that mRNA-based vaccines will have 65% of the Covid-19 vaccine market share in 2021 and 2022.

According to FactSet, the analyst consensus puts Modernas (MRNA) Covid-19 vaccine sales at $8.5 billion in 2025 and BioNTech s (BNTX) at $3.8 billion.

Longer-term, we see opportunity for CVAC to gain share based on its pricing discount relative to PFE/BNTX and MRNA, Fernandez wrote.

In addition to its Covid-19 vaccine, the company has a pipeline of prophylactic vaccines and cancer vaccines. The company also has a number of partnerships with GlaxoSmithKline (GSK), including a collaboration on a next-generation Covid-19 vaccine.

With >$1B in cash on the balance sheet, CVAC is well funded, but the pipeline is too early (or speculative in the case of intratumoral cancer vaccines) to attribute significant value, Fernandez wrote.

For now, the stocks valuation hinges on the outcome of the ongoing Phase 2b/3 study of its Covid-19 vaccine. Fernandez wrote that he expects the vaccine to demonstrate efficacy of at least 80%.

Write to Josh Nathan-Kazis at josh.nathan-kazis@barrons.com

Read this article:

There's Room for More Players in the Covid-19 Vaccine Market, Analyst Says - Barron's

US Covid-19 vaccination efforts may start to slow, official says. Here’s why – CNN

April 26, 2021

"We're going continue to make progress, it might not be as fast as the first 50% (of the population vaccinated), I think that it's going to be slower. But I think we're going to continue to get there," said Andy Slavitt, White House senior adviser for Covid-19 response.

Experts say the US is facing some major challenges when it comes to getting more shots into arms, including vaccine hesitancy.

What a gradual return to normal will look like

Experts including Dr. Anthony Fauci estimate between 70% to 85% of the country needs to be immune to the virus -- either through previous infection or from vaccination -- to suppress its spread.

But even before hitting those percentages, the country will reach a point where Covid-19 cases will begin going down dramatically as more people get vaccinated, Fauci said.

But it's not there yet.

"Right now, we're averaging about 60,000 cases per day," Fauci told CNN on Sunday. "As we get lower and lower and lower, you're going to be seeing a gradual diminution of the restrictions and a more progressive moving towards normality."

It will be a gradual return to normal, as Americans can begin enjoying outdoor activities, travel, sporting events, theaters and restaurants "little by little," Fauci said.

"The past trends, when we saw cases start to decline, we were somewhat skeptical because we knew a lot of those declines were a result of behavioral changes, people pulling back more, taking more precautions and then as soon as we sort of let our guard down, we saw cases surge again," he said Sunday on CBS' "Face the Nation."

"Right now, the declines that we're seeing we can take to the bank," Gottlieb added. "I think we could feel more assured because they're being driven by vaccinations and greater levels of population-wide immunity -- not just from vaccination but also from prior infection."

More guidance could be coming

"In the next few days very likely, the CDC will be coming out with updating their guidelines of what people who are vaccinated can do and even some who are not vaccinated," he told CNN.

While the Covid-19 safety risks appear to be much lower outdoors, it's still important to consider several factors when deciding whether to mask up or not, one expert said.

"You do have to consider the rate of viral transmission in your community, the vaccination rates in your community and what kind of outdoor setting you're in," Dr. Richina Bicette of the Baylor College of Medicine told CNN Sunday. "A packed concert where people are shoulder-to-shoulder is going to be riskier than an outdoor volleyball game where you have a large area and people spread apart."

Some Americans are missing their second shots

As more shots are making it into arms, a growing number of Americans seem to be missing their scheduled second dose, according to data from the CDC.

About 3.4% had missed that second appointment back in March. About 8% of Americans have missed it now, the data show.

But it's not an exact count.

If a person got their two Covid-19 vaccine doses from different reporting entities -- for example, first from a state-run clinic and then from a local health clinic -- the two doses may not have been linked together, a CDC spokeswoman said.

Confidence in J&J vaccine fell before pause lifted

Confidence in the Johnson & Johnson Covid-19 vaccine lowered after a pause was put in place by the CDC and FDA, according to a poll released Monday by ABC and the Washington Post.

"Fewer than half of Americans see the Johnson & Johnson coronavirus vaccine as safe and barely more than a fifth of those not yet vaccinated would be willing to take it," found the poll, even though overall intentions to get vaccinated have risen since January.

The poll found that 73% of unvaccinated respondents said that they were unwilling to get the J&J vaccine and 41% said that it was very or somewhat unsafe.

That left 22% of unvaccinated respondents who said they would be willing to get J&J's vaccine if it were put back in use.

The number of respondents who saw the J&J vaccine as very or somewhat safe was 46%, compared with 71% who saw the Moderna vaccine as safe and 73% who viewed the Pfizer vaccines as safe.

Fauci: US has 'moral responsibility' to help India

The US has a "moral responsibility" to help India and the rest of the world to fight the pandemic, Fauci told CNN on Sunday.

"The United States and India are the two countries now that have suffered the most. They've been allies of ours. They've been people that we have over the decades and decades had strong collaboration and cooperation with."

"Getting them vaccinations is certainly on the table" and being discussed as a possibility, Fauci said Sunday.

Helping India matters to the US for several reasons, US Surgeon General Dr. Vivek Murthy told MSNBC on Sunday.

"First and foremost because we are human beings and we should care about what happens to other human beings around the world," Murthy said.

Secondly, he said, the uncontrolled spread of the virus in other parts of the world increases the chances of further mutations and variants of the coronavirus that could eventually pose a problem to vaccines, he said.

"And that means that those viruses, those mutant viruses, those new variants, could travel here to the US and cause real challenges here," he added.

CNN's Jessica Firger, Naomi Thomas, Rashard Rose, Barbara Starr, Elizabeth Cohen and Maggie Fox contributed to this report.

The rest is here:

US Covid-19 vaccination efforts may start to slow, official says. Here's why - CNN

Page 446«..1020..445446447448..460470..»